SC 13G/A

AMENDMENT NO. 8 TO THE SCHEDULE 13D

Company: Xenon Pharmaceuticals Inc.
Filed: February 14, 2020
Accession Number: 0000921895-20-000548

View Document ↗ View on SEC.gov ↗